EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder

Henning Plage, Kira Furlano, Sebastian Hofbauer, Florian Roßner, Simon Schallenberg, Sefer Elezkurtaj, Maximilian Lennartz, Andreas Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski und 14 weitere

International Urology and Nephrology · 2024

DOI: 10.1007/s11255-024-04319-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Henning Plage und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin …. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Alkaline Phosphatase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charité - Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Placental alkaline phosphatase (PLAP) is a protein with a poorly understood function that is normally only expressed in the placenta. In cancer, PLAP expression is a hallmark of germ cell neoplasms, but it can also occur in urothelial carcinoma. To evaluate the potential clinical significance of PLAP expression in bladder cancer, Methods PLAP protein was analyzed by immunohistochemistry in more than 2500 urothelial bladder carcinomas in a tissue microarray format.

Results

PLAP staining was absent in normal urothelial cells but was observed in 15.9% of urothelial carcinomas, including 282 (11.5%) with weak, 57 (2.3%) with moderate, and 51 (2.1%) with strong staining. PLAP positivity occurred in 4.1% of 413 pTa G2 low-grade, 10.2% of 176 pTa G2 high-grade, and 7.2% of 97 pTa G3 tumors (p = 0.0636). As compared to pTa tumors, the PLAP positivity rate was markedly higher in 1341 pT2-4 carcinomas (19.8%, p < 0.0001). Within pT2-4 carcinomas, PLAP staining was unrelated to pT, pN, grade, L-status, V-status, overall survival, recurrence-free survival, and cancer-specific survival (p > 0.25). However, PLAP positivity was linked to p16 positivity (p = 0.0185), GATA3 positivity (p < 0.0001), and p63 expression loss (p = 0.0456).

Conclusion

In summary, these data show that PLAP is expressed in a significant fraction of pT2-4 urothelial carcinomas, unrelated to cancer aggressiveness but associated with specific molecular features. Once anti-PLAP cancer drugs become effective, urothelial carcinoma is a candidate tumor entity for clinical evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, Transitional CellAlkaline PhosphataseHumansNeoplasm InvasivenessGPI-Linked ProteinsFemaleMaleImmunohistochemistryUrotheliumBiomarkers, TumorTissue Array AnalysisAgedMiddle AgedNeoplasm StagingIsoenzymes

Stichwörter der Autor:innen

BiomarkerBladder CancerPLAPPrognosisTissue Micro Array

Substanzen

alkaline phosphatase, placentalGPI-Linked ProteinsAlkaline PhosphataseBiomarkers, TumorIsoenzymes

Autor:innen und Institutionen

  • Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany. henning.p…
  • Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
  • Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and, Berlin Institute of Health, Berlin, Germany.
  • Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany.
  • Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Förderung

  • Charité - Universitätsmedizin Berlin

Zitieren

APA

Plage, H., Furlano, K., Hofbauer, S., Roßner, F., Schallenberg, S., Elezkurtaj, S., Lennartz, M., Marx, A., Samtleben, H., Fisch, M., Rink, M., Slojewski, M., Kaczmarek, K., Ecke, T., Klatte, T., Koch, S., Adamini, N., Minner, S., Simon, R., …, & Weinberger, S. (2024). PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04319-8

Vancouver

Plage H, Furlano K, Hofbauer S, Roßner F, Schallenberg S, Elezkurtaj S, et al. PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04319-8

BibTeX
@article{Plage2024,
  author = {Plage, Henning and Furlano, Kira and Hofbauer, Sebastian and Roßner, Florian and Schallenberg, Simon and Elezkurtaj, Sefer and Lennartz, Maximilian and Marx, Andreas and Samtleben, Henrik and Fisch, Margit and Rink, Michael and Slojewski, Marcin and Kaczmarek, Krystian and Ecke, Thorsten and Klatte, Tobias and Koch, Stefan and Adamini, Nico and Minner, Sarah and Simon, Ronald and Sauter, Guido and Weischenfeldt, Joachim and Schlomm, Thorsten and Horst, David and Zecha, Henrik and Kluth, Martina and Weinberger, Sarah},
  title = {PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder},
  journal = {International Urology and Nephrology},
  year = {2024},
  doi = {10.1007/s11255-024-04319-8}
}
Kostenlos starten →